Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mohammad

Showing results (341-350 of 367) with videos related to

Pageof 37
Sort By:
Cancer Research Communications|May 16, 2022
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant CancersHusain Yar Khan, Misako Nagasaka, Yiwei Li, et al.
Therapeutic Advances in Medical Oncology|October 21, 2025
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)Bora Lim, Angela Marx, Megumi Kai, et al.
Molecular Cancer Therapeutics|July 13, 2021
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to EverolimusGabriel B Mpilla, Md Hafiz Uddin, Mohammed N Al-Hallak, et al.
Clinical and Translational Medicine|December 22, 2023
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse modelMd Hafiz Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, et al.
Frontiers in Cardiovascular Medicine|October 29, 2025
Invasive treatment strategy for older patients with non-ST-elevation acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trialsVaibhav Vats, Rai Dilawar Shahjehan, Bavurothu Sharanya Kumar, et al.
Annals of Medicine and Surgery (2012)|September 6, 2024
Minimally invasive spleen-preserving surgery to treat primary splenic hydatidosis: short and long-term outcomes: a cohort studyAnas Aljaiuossi, Saleh A Ba-Shammakh, Mohammad Bani Hani, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancersHusain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
Cancer Letters|September 25, 2024
RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growthSahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
Annals of Medicine and Surgery (2012)|February 12, 2026
Transulnarversus transradial artery access in patients undergoing cardiac procedures: a systematic review and meta-analysisMohamed Falah Abdullah Al-Shamari, Sofian Mohamed M Zreigh, Ahmed A Mosa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I StudyErlene K Seymour, Husain Yar Khan, Yiwei Li, et al.
Pageof 37

Showing results (341-350 of 367) with videos related to

Sort By:
Pageof 37
Cancer Research Communications|May 16, 2022
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant CancersHusain Yar Khan, Misako Nagasaka, Yiwei Li, et al.
Therapeutic Advances in Medical Oncology|October 21, 2025
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)Bora Lim, Angela Marx, Megumi Kai, et al.
Molecular Cancer Therapeutics|July 13, 2021
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to EverolimusGabriel B Mpilla, Md Hafiz Uddin, Mohammed N Al-Hallak, et al.
Clinical and Translational Medicine|December 22, 2023
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse modelMd Hafiz Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, et al.
Frontiers in Cardiovascular Medicine|October 29, 2025
Invasive treatment strategy for older patients with non-ST-elevation acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trialsVaibhav Vats, Rai Dilawar Shahjehan, Bavurothu Sharanya Kumar, et al.
Annals of Medicine and Surgery (2012)|September 6, 2024
Minimally invasive spleen-preserving surgery to treat primary splenic hydatidosis: short and long-term outcomes: a cohort studyAnas Aljaiuossi, Saleh A Ba-Shammakh, Mohammad Bani Hani, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancersHusain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
Cancer Letters|September 25, 2024
RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growthSahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
Annals of Medicine and Surgery (2012)|February 12, 2026
Transulnarversus transradial artery access in patients undergoing cardiac procedures: a systematic review and meta-analysisMohamed Falah Abdullah Al-Shamari, Sofian Mohamed M Zreigh, Ahmed A Mosa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I StudyErlene K Seymour, Husain Yar Khan, Yiwei Li, et al.
Pageof 37